Navigation Links
Depomed To Present At Morgan Stanley 2014 Global Healthcare Conference
Date:8/25/2014

NEWARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City.

The presentation at the Morgan Stanley conference is scheduled for 2:40 pm ET (11:40 am PT) on Wednesday September 10, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30 days on the company's website.

About Depomed 
Depomed is a specialty pharmaceutical company that commercializes products for pain and CNS disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.

INVESTOR CONTACT:
August J. Moretti  
Depomed, Inc. 510.744.8000
amoretti@depomed.com


'/>"/>
SOURCE Depomed, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Depomed Reports Second Quarter 2014 Financial Results
2. Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer
3. Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
4. Depomed Announces District Court Order in ANDA Litigation
5. Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer
6. Depomed To Present At Piper Jaffray 2013 Healthcare Conference
7. Depomed Reports Third Quarter 2013 Financial Results
8. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
9. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
10. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
11. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 This report on the opioid induced ... of the global market. Large number of chronic pain ... constipation is a major side effect of consumption of ... targeted therapy has been prescribed to treat opioid induced ... medicines, and growing awareness about the therapy are the ...
(Date:1/19/2017)... YORK , January 19, 2017 According ... market for cryotherapy is set to witness a CAGR of 6.5% ... North America will continue to be the leading market ... ... Suppliers are emphasizing on ensuring affordable and adequate supply of ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... MB Business Capital, a ... senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, dba MedPro Healthcare ... a recapitalization of MedPro led by Harren Equity Partners. Brightwood Capital Advisors ...
(Date:1/19/2017)... Texas (PRWEB) , ... January 19, 2017 , ... Students ... GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship and ... The competition begins Feb. 1, and the deadline is May 31, with the winner ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) is ... passionate about making a difference in the lives of the next generation of ... nonprofit healthcare educational institution, has more than 30,000 alumni and employs more than ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... ... 2017 , ... St. Catherine’s Village announced that a limited number of rooms ... facility on the grounds of the St. Catherine’s Village campus in Madison, Mississippi that ... nursing home in Mississippi for the second year in a row by readers of ...
Breaking Medicine News(10 mins):